Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gyula Tóth

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Magyar Onkologia|June 11, 2020
[Oncology PET radiopharmaceuticals in clinic and research in 2020]Pál Mikecz, Anikó Fekete, Gyula Tóth, et al.
The Journal of Chemical Physics|July 11, 2006
Multiscale approach to CO2 hydrate formation in aqueous solution: phase field theory and molecular dynamics. Nucleation and growthGyörgy Tegze, Tamás Pusztai, Gyula Tóth, et al.
In Vivo (Athens, Greece)|April 29, 2004
Modulation of multidrug resistance and apoptosis of cancer cells by selected carotenoidsJoseph Molnár, Nóra Gyémánt, Ilona Mucsi, et al.
Orvosi Hetilap|June 25, 2002
[Synthesis of radiopharmaceuticals for PET investigations]Pál Mikecz, Gyula Tóth, Géza Horváth, et al.
Orvosi Hetilap|December 21, 2025
[18F-PSMA PET/CT imaging following biochemical recurrence of prostate cancer]Domonkos Nádasdy-Horváth, Márton Piroska, Sándor Czibor, et al.
Pharmaceuticals (Basel, Switzerland)|November 27, 2024
Different PSMA Radiopharmaceuticals: A Comparative Study of [<sup>18</sup>F]F-PSMA-1007, [<sup>18</sup>F]F-JK-PSMA-7, and [<sup>99m</sup>Tc]Tc-PSMA-I&S in the Skeletal SystemZsófia Sára Mikó, László Varga, István Farkas, et al.
Cancers|April 23, 2022
Development and Functional Characterization of a Versatile Radio-/Immunotheranostic Tool for Prostate Cancer ManagementClaudia Arndt, Ralf Bergmann, Franziska Striese, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Magyar Onkologia|June 11, 2020
[Oncology PET radiopharmaceuticals in clinic and research in 2020]Pál Mikecz, Anikó Fekete, Gyula Tóth, et al.
The Journal of Chemical Physics|July 11, 2006
Multiscale approach to CO2 hydrate formation in aqueous solution: phase field theory and molecular dynamics. Nucleation and growthGyörgy Tegze, Tamás Pusztai, Gyula Tóth, et al.
In Vivo (Athens, Greece)|April 29, 2004
Modulation of multidrug resistance and apoptosis of cancer cells by selected carotenoidsJoseph Molnár, Nóra Gyémánt, Ilona Mucsi, et al.
Orvosi Hetilap|June 25, 2002
[Synthesis of radiopharmaceuticals for PET investigations]Pál Mikecz, Gyula Tóth, Géza Horváth, et al.
Orvosi Hetilap|December 21, 2025
[18F-PSMA PET/CT imaging following biochemical recurrence of prostate cancer]Domonkos Nádasdy-Horváth, Márton Piroska, Sándor Czibor, et al.
Pharmaceuticals (Basel, Switzerland)|November 27, 2024
Different PSMA Radiopharmaceuticals: A Comparative Study of [<sup>18</sup>F]F-PSMA-1007, [<sup>18</sup>F]F-JK-PSMA-7, and [<sup>99m</sup>Tc]Tc-PSMA-I&S in the Skeletal SystemZsófia Sára Mikó, László Varga, István Farkas, et al.
Cancers|April 23, 2022
Development and Functional Characterization of a Versatile Radio-/Immunotheranostic Tool for Prostate Cancer ManagementClaudia Arndt, Ralf Bergmann, Franziska Striese, et al.
Pageof 2